AU2001234689A1 - Bivalent phenylene inhibitors of factor xa - Google Patents
Bivalent phenylene inhibitors of factor xaInfo
- Publication number
- AU2001234689A1 AU2001234689A1 AU2001234689A AU3468901A AU2001234689A1 AU 2001234689 A1 AU2001234689 A1 AU 2001234689A1 AU 2001234689 A AU2001234689 A AU 2001234689A AU 3468901 A AU3468901 A AU 3468901A AU 2001234689 A1 AU2001234689 A1 AU 2001234689A1
- Authority
- AU
- Australia
- Prior art keywords
- inhibitors
- factor
- bivalent phenylene
- bivalent
- phenylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/195—Radicals derived from nitrogen analogues of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17947700P | 2000-02-01 | 2000-02-01 | |
| US60179477 | 2000-02-01 | ||
| PCT/US2001/003175 WO2001056989A2 (en) | 2000-02-01 | 2001-02-01 | Inhibitors of factor xa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001234689A1 true AU2001234689A1 (en) | 2001-08-14 |
Family
ID=22656751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001234689A Abandoned AU2001234689A1 (en) | 2000-02-01 | 2001-02-01 | Bivalent phenylene inhibitors of factor xa |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20020065303A1 (en) |
| AU (1) | AU2001234689A1 (en) |
| WO (1) | WO2001056989A2 (en) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60226875D1 (en) | 2001-08-15 | 2008-07-10 | Du Pont | ORTHOSUBSTITUTED ARYLAMIDES FOR COMBATING WIRELESS PESTS |
| US7241767B2 (en) | 2002-01-22 | 2007-07-10 | E. I. Du Pont De Nemours And Company | Quinazoline(di)ones for invertebrate pest control |
| EP2402310A1 (en) | 2002-05-24 | 2012-01-04 | Millennium Pharmaceuticals, Inc. | CCR9 inhibitors and methods of use thereof |
| US6838565B2 (en) * | 2002-07-26 | 2005-01-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Substituted benzoic acid amides, their preparation and their use as pharmaceutical compositions |
| US7741519B2 (en) | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
| US7227035B2 (en) | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
| US20070021466A1 (en) * | 2002-11-18 | 2007-01-25 | Solomon Ungashe | CCR2 inhibitors and methods of use thereof |
| US7420055B2 (en) * | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
| JP4611746B2 (en) * | 2002-11-18 | 2011-01-12 | ケモセントリックス， インコーポレイテッド | Arylsulfonamide |
| PT1569912E (en) | 2002-12-03 | 2015-09-15 | Pharmacyclics Llc | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| US6979750B1 (en) | 2003-04-18 | 2005-12-27 | The Regents Of The University Of California | Thyronamine derivatives and analogs and methods of use thereof |
| US7321065B2 (en) | 2003-04-18 | 2008-01-22 | The Regents Of The University Of California | Thyronamine derivatives and analogs and methods of use thereof |
| CA2552087C (en) * | 2004-01-30 | 2011-01-25 | Euro-Celtique S.A. | Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| JP3997255B2 (en) | 2004-02-13 | 2007-10-24 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | Androgen receptor modulator |
| US7371743B2 (en) | 2004-02-28 | 2008-05-13 | Boehringer Ingelheim International Gmbh | Carboxylic acid amides, the preparation thereof and their use as medicaments |
| BRPI0509759A (en) | 2004-04-13 | 2007-10-16 | Warner Lambert Co | androgen modulators |
| CA2562672C (en) | 2004-04-22 | 2009-09-29 | Warner-Lambert Company Llc | 4-cyano-phenoxy derivatives as androgen modulators |
| WO2006006065A1 (en) | 2004-07-08 | 2006-01-19 | Warner-Lambert Company Llc | Androgen modulators |
| EP1847527A4 (en) * | 2005-02-02 | 2009-04-08 | Ajinomoto Kk | Novel benzamidine compound |
| TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
| SI2404919T1 (en) | 2005-11-08 | 2013-12-31 | Vertex Pharmaceuticals Incorporated | Heterocyclic compound useful as a modulator of ATP-binding cassette transporters. |
| US7671221B2 (en) | 2005-12-28 | 2010-03-02 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| US7754739B2 (en) | 2007-05-09 | 2010-07-13 | Vertex Pharmaceuticals Incorporated | Modulators of CFTR |
| CA2686838C (en) | 2007-05-09 | 2017-03-14 | Vertex Pharmaceuticals Incorporated | Modulators of cftr |
| CA2706920C (en) | 2007-12-07 | 2018-02-13 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| PT2639222T (en) | 2007-12-07 | 2016-11-01 | Vertex Pharma | Process for producing cycloalkylcarboxiamido-pyridine benzoic acids |
| ES2647531T3 (en) | 2008-02-28 | 2017-12-22 | Vertex Pharmaceuticals Incorporated | Heteroaryl derivatives as CFTR modulators |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| US8344018B2 (en) | 2008-07-14 | 2013-01-01 | Gilead Sciences, Inc. | Oxindolyl inhibitor compounds |
| JP5640006B2 (en) | 2008-07-14 | 2014-12-10 | ギリアード サイエンシーズ， インコーポレイテッド | Condensed heterocyclic inhibitors of histone deacetylases and / or cyclin-dependent kinases |
| US8134000B2 (en) | 2008-07-14 | 2012-03-13 | Gilead Sciences, Inc. | Imidazolyl pyrimidine inhibitor compounds |
| JP2011529504A (en) | 2008-07-28 | 2011-12-08 | ギリアード サイエンシーズ， インコーポレイテッド | Cycloalkylidene histone deacetylase inhibitor compounds and heterocycloalkylidene histone deacetylase inhibitor compounds |
| PT2385938E (en) | 2009-01-12 | 2015-06-02 | Pfizer Ltd | Sulfonamide derivatives |
| TW201100398A (en) | 2009-03-31 | 2011-01-01 | Arqule Inc | Substituted indolo-pyridinone compounds |
| AU2010259042A1 (en) | 2009-06-08 | 2011-12-15 | Gilead Sciences, Inc. | Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds |
| KR20120031170A (en) | 2009-06-08 | 2012-03-30 | 길리애드 사이언시즈, 인코포레이티드 | Alkanoylamino benzamide aniline hdac inhibitor compounds |
| HRP20211752T1 (en) | 2010-04-07 | 2022-02-18 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof |
| CA2804173C (en) | 2010-07-09 | 2015-01-13 | Pfizer Limited | Sulfonamide nav1.7 inhibitors |
| PL3068392T3 (en) | 2013-11-12 | 2021-07-19 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases |
| JP6494757B2 (en) | 2014-11-18 | 2019-04-03 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | Process for high-throughput high performance liquid chromatography |
| TW201920081A (en) | 2017-07-11 | 2019-06-01 | 美商維泰克斯製藥公司 | Carboxamides as modulators of sodium channels |
| EP3749697A4 (en) | 2018-02-05 | 2021-11-03 | Bio-Rad Laboratories, Inc. | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand |
| PL3752501T3 (en) | 2018-02-13 | 2023-08-21 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| US10899735B2 (en) | 2018-04-19 | 2021-01-26 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
| JP7105359B2 (en) | 2018-07-13 | 2022-07-22 | ギリアード サイエンシーズ， インコーポレイテッド | PD-1/PD-L1 inhibitor |
| AU2019366355B2 (en) | 2018-10-24 | 2022-10-13 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA928276B (en) * | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| JP3004362B2 (en) * | 1994-12-02 | 2000-01-31 | 山之内製薬株式会社 | Novel amidinonaphthyl derivative or salt thereof |
| DE19530996A1 (en) * | 1995-08-23 | 1997-02-27 | Boehringer Mannheim Gmbh | Cyclic guanidines, process for their preparation and pharmaceuticals |
| TW542822B (en) * | 1997-01-17 | 2003-07-21 | Ajinomoto Kk | Benzamidine derivatives |
| CN1268116A (en) * | 1997-08-27 | 2000-09-27 | 橘生药品工业株式会社 | 3-amidinoaniline derivatives activated blood coagulation factor X inhibitors, and intermediates for producing both |
| WO1999011617A1 (en) * | 1997-09-01 | 1999-03-11 | Yamanouchi Pharmaceutical Co., Ltd. | Novel naphthamide derivatives or salts thereof |
| JPH11140040A (en) * | 1997-11-06 | 1999-05-25 | Kissei Pharmaceut Co Ltd | 3-amidinophenyl ether derivative, activated blood coagulation factor x inhibitor and intermediate for producing the same |
| RU2197478C2 (en) * | 1997-11-20 | 2003-01-27 | Тейдзин Лимитед | Derivatives of biphenylamidine |
| AU1689999A (en) * | 1997-12-25 | 1999-07-19 | Daiichi Pharmaceutical Co., Ltd. | Medicinal composition for percutaneous administration |
| ATE272630T1 (en) * | 1998-04-10 | 2004-08-15 | Japan Tobacco Inc | AMIDINE COMPOUNDS |
| US6350761B1 (en) * | 1999-07-30 | 2002-02-26 | Berlex Laboratories, Inc. | Benzenamine derivatives as anti-coagulants |
-
2001
- 2001-02-01 US US09/773,375 patent/US20020065303A1/en not_active Abandoned
- 2001-02-01 WO PCT/US2001/003175 patent/WO2001056989A2/en active Application Filing
- 2001-02-01 AU AU2001234689A patent/AU2001234689A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001056989A3 (en) | 2002-02-28 |
| US20020065303A1 (en) | 2002-05-30 |
| WO2001056989A2 (en) | 2001-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001234689A1 (en) | Bivalent phenylene inhibitors of factor xa | |
| AU2001273040A1 (en) | Factor xa inhibitors | |
| AU6762400A (en) | Inhibitors of factor xa | |
| AU5723500A (en) | Inhibitors of factor xa | |
| AU5158100A (en) | Inhibitors of factor xa | |
| AU5283900A (en) | Inhibitors of factor xa | |
| AU3857300A (en) | Inhibitors of factor xa | |
| AU2002350217A1 (en) | Glycinamides as factor xa inhibitors | |
| AU2001249399A1 (en) | Isoquinolone inhibitors of factor xa | |
| IL148698A0 (en) | INHIBITORS OF FACTOR Xa | |
| HK1070352A1 (en) | Indole-2-carboxamides as factor xa inhibitors | |
| AU2001282009A1 (en) | Non-steroidal inflammation inhibitors | |
| AU2002365896A1 (en) | SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS | |
| AU5284000A (en) | Inhibitors of factor xa | |
| AU2001249397A1 (en) | Oxindole inhibitors of factor xa | |
| AU2002303264A1 (en) | Fused heterocyclic inhibitors of factor xa | |
| AU2001294824A1 (en) | Piperazine based inhibitors of factor xa | |
| AU2001297648A1 (en) | Substituted carboxamides as inhibitors of factor xa | |
| IL162454A0 (en) | Pyrrolidine-2-ones as factor xa inhibitors | |
| AU2001255090A1 (en) | Cdk inhibitors having 3-hydroxychromen-4-one structure | |
| AU2001281843A1 (en) | Dipeptide inhibitors for the blood-clotting factor Xa | |
| AU2002222933A1 (en) | Inhibitors of factor xa | |
| PL350941A1 (en) | Pyrazole-3-on-derivative as factor xa inhibitors | |
| AU2002338734A1 (en) | Use of phosphorodiesterase IV inhibitors | |
| AU2003296393A1 (en) | Factor xa inhibitors |